Compare CSTL & SNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSTL | SNCY |
|---|---|---|
| Founded | 2007 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 661.7M | 652.6M |
| IPO Year | 2019 | 2021 |
| Metric | CSTL | SNCY |
|---|---|---|
| Price | $39.54 | $13.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $38.67 | $19.17 |
| AVG Volume (30 Days) | 588.2K | ★ 836.8K |
| Earning Date | 11-03-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.51 |
| EPS | N/A | ★ 1.05 |
| Revenue | $343,530,000.00 | ★ $1,106,213,000.00 |
| Revenue This Year | N/A | $6.16 |
| Revenue Next Year | N/A | $9.63 |
| P/E Ratio | ★ N/A | $13.05 |
| Revenue Growth | ★ 10.15 | 4.27 |
| 52 Week Low | $14.59 | $8.10 |
| 52 Week High | $40.61 | $18.59 |
| Indicator | CSTL | SNCY |
|---|---|---|
| Relative Strength Index (RSI) | 80.57 | 64.90 |
| Support Level | $33.03 | $11.24 |
| Resistance Level | $35.49 | $13.90 |
| Average True Range (ATR) | 1.56 | 0.64 |
| MACD | 0.33 | 0.17 |
| Stochastic Oscillator | 85.93 | 92.64 |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
Sun Country Airlines Holdings Inc operates low-cost air carriers. The business has two operating segments: Passenger and Cargo. The passenger segment has two internal passenger groups Scheduled service and Charter. The Cargo segment provides air cargo services. The majority of the revenue is from the passenger segment.